Notifiable HAI Reporting

Healthcare-Associated Infections (HAIs) as Reportable Diseases

In January 2013, the Georgia Notifiable Disease/Conditions List was updated to include HAI NHSN data to be reported by healthcare facilities participating in Centers for Medicaid and Medicare Services (CMS) programs.

Healthcare facilities must confer rights to the State of Georgia Users Group of the National Healthcare Safety Network (NHSN) and follow NHSN protocols to complete HAI reporting. Acute care hospitals are required to report CLABSI, CAUTI, CDI, MRSA, SSI COLO, and SSI HYST. Long-term acute care hospitals are required to report CLABSI, CAUTI, VAE, CDI, and MRSA. Inpatient rehabilitation facilities are required to report CAUTI, CDI, and MRSA.

Data entered into NHSN and accessed by DPH will be protected and confidential. Data will only be shared in aggregate.

DPH Documentation for HAIs as Notifiable Disease

Instructions for Joining and Confirmation of Rights to the State User’s Group on NHSN

CMS NHSN Reporting

Carbapenem-Resistant Enterobacteriaceae (CRE)

When:  July 2018

What:  Reporting and submitting isolates within 7 days for Carbapenem-Resistant Enterobacterales (CRE) defined as any Klebsiella spp., Enterobacter spp., or Escherichia coli that is resistant to carbapenems or that produces carbapenemase; see Download this pdf file.  Laboratory CRE Reporting and Submission Guidelines .

(Note: Reporting and submission of other healthcare-associated carabapenamse-resistant organism isolates, including other CR-genera in the order, Enterobacterales, CR-Pseudomonas spp., and CR-Acinetobacter spp., is strongly encouraged but not required; contact [email protected] for more information.)

Laboratories can report via electronic laboratory reporting, secure email to [email protected] within 7 days.

Patient information can be entered into the CRE case report form in SendSS. 

To create a SendSS authorized user account, complete a registration form at https://sendss.state.ga.us/sendss/login.screen.

For SendSS related questions, please email: [email protected].

CRE Isolate Submission

Background and Justification:

http://www.cste.org/resource/resmgr/2015PS/2015PSFinal/15-ID-05.pdf

https://cdn.ymaws.com/www.cste.org/resource/resmgr/2017PS/2017PSFinal/17-ID-04.pdf

Candida auris: Call for Cases

Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and is associated with high mortality. C. auris can spread from patient to patient within healthcare facilities and cause prolonged healthcare-associated outbreaks.

C. auris can be misidentified as a number of different organisms when using traditional phenotypic methods for yeast identification.

When to suspect C. auris: https://www.cdc.gov/fungal/candida-auris/recommendations.html

Healthcare facilities or laboratories that suspect they have a patient with C. auris infection should contact the HAI team at GDPH ([email protected] or 404-657-2588) and CDC ([email protected]) immediately for guidance.

Background and Justification:

http://www.cste.org/resource/resmgr/2017PS/2017PSFinal/17-ID-03.pdf 

Page last updated 5/19/2022